VK
0000-0003-4468-3459 About
Dr. Vikas Kumar obtained his M.Sc. in Microbiology and M.Phil. in Biotechnology from Himachal Pradesh University, Shimla. Thereafter he did his Ph.D. from Gyeongsang National University South Korea. Currently, Dr. Kumar serves as a Postdoctoral researcher at BCMaterials, Spain, where he work under IKUR research program. His research interest includes the identification of Anti-microbial and Anti-cancer small molecules using the Computational Drug Design and Biological validation methods.
Employment
-
Basque Center for Materials, Applications and Nanostructures2023 - Present
Education
-
Basque Center for Materials, Applications and Nanostructures Post-Doctoral Researcher2023 - Present
Projects & Funding
Projects & funding information is unavailable.
Publications (33)
- Quantum intelligence in drug discovery: Advancing insights with quantum machine learning Save
- Modeling of FAK-PROTAC candidates from GSK2256098 analogs for targeted protein degradation Save
- Uncovering potential CDK9 inhibitors from natural compound databases through docking-based virtual screening and MD simulations Save
- Discovery of Novel Allosteric SHP2 Inhibitor Using Pharmacophore-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and Principal Component Analysis Save
- Computational insights into allosteric inhibition of focal adhesion kinase: A combined pharmacophore modeling and molecular dynamics approach Save
- Association of Phosphorylated Pyruvate Dehydrogenase with Pyruvate Kinase M2 Promotes PKM2 Stability in Response to Insulin Save
- Investigation of Macrocyclic mTOR Modulators of Rapamycin Binding Site via Pharmacoinformatics Approaches Save
- Identification of Activated Cdc42-Associated Kinase Inhibitors as Potential Anticancer Agents Using Pharmacoinformatic Approaches Save
- Cycloastragenol activation of telomerase improves β-Klotho protein level and attenuates age-related malfunctioning in ovarian tissues Save
- A decade of machine learning-based predictive models for human pharmacokinetics: Advances and challenges Save